Phytochemical Profiling, Toxicological Safety, and Antihyperglycemic Effects of Fouquieria splendens Engelm. Foliar Extract in Streptozotocin-Induced Diabetic Rats
Future Pharmacology · 04.11.2025 · 5 (4) · 64
DOI: 10.3390/futurepharmacol5040064 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Pharmacology, online erschienen am 04.11.2025. Verfasst von Karen Montserrat Román-Casiano und 7 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Instituto Politécnico Nacional, the Programa de Becas de Estímulo Institucional de Formación de Investigadores (BEIFI, Institutional Program for Researcher Training Scholarships) of the Insti….
Abstract (Originalsprache)
Background/Objectives: Fouquieria splendens Engelm. is a medicinal plant traditionally used in North America for treating metabolic disorders; however, its antihyperglycemic properties and safety profiles remain poorly studied. We investigated the phytochemical composition, oral acute toxicity, mutagenicity, and antihyperglycemic activity of the foliar ethanolic extract of F. splendens (EFS).
Methods
Phytochemical analysis was performed using ultra-performance liquid chromatography–mass spectrometry. Acute toxicity and mutagenicity were evaluated following the OECD guidelines. Antihyperglycemic activity was assessed in streptozotocin-induced diabetic rats treated with EFS (200 mg/kg) alone or in combination with metformin for 30 days.
Results
Eleven phenolic compounds were identified in the EFS, including ellagic acid, morin, apigenin, and luteolin 7-Oglucoside. EFS was non-mutagenic and had an LD50 of >2000 mg/kg. This treatment significantly reduced blood glucose levels and enhanced the effect of metformin in diabetic rats. Histopathological analysis showed preserved morphology in the pancreatic, hepatic, and renal tissues of the treated animals.
Conclusions
EFS exhibited significant antihyperglycemic activity and a favorable safety profile, supporting its potential as a complementary phytotherapeutic agent for diabetes management. These results highlight the pharmacological value of F. splendens and promote the exploration of native plants as adjuncts for chronic disease therapy.
Förderung
- the Instituto Politécnico Nacional
- the Programa de Becas de Estímulo Institucional de Formación de Investigadores (BEIFI, Institutional Program for Researcher Training Scholarships) of the Insti…
Zitieren
APA
Román-Casiano, K. M., Bermudes-Contreras, J. D., Cornejo-Garrido, J., Delgado-Alvarado, E. A., Uribe-Soto, J. N., Ruiz-Baca, E., Gutiérrez-Velázquez, M. V., & Torres-Ricario, R. (2025). Phytochemical Profiling, Toxicological Safety, and Antihyperglycemic Effects of Fouquieria splendens Engelm. Foliar Extract in Streptozotocin-Induced Diabetic Rats. Future Pharmacology, 5(4), 64. https://doi.org/10.3390/futurepharmacol5040064
Vancouver
Román-Casiano KM, Bermudes-Contreras JD, Cornejo-Garrido J, Delgado-Alvarado EA, Uribe-Soto JN, Ruiz-Baca E, et al. Phytochemical Profiling, Toxicological Safety, and Antihyperglycemic Effects of Fouquieria splendens Engelm. Foliar Extract in Streptozotocin-Induced Diabetic Rats. Future Pharmacology. 2025;5(4):64. doi:10.3390/futurepharmacol5040064
BibTeX
@article{RomnCasiano2025,
author = {Román-Casiano, Karen Montserrat and Bermudes-Contreras, Juan David and Cornejo-Garrido, Jorge and Delgado-Alvarado, Eli Amanda and Uribe-Soto, José Natividad and Ruiz-Baca, Estela and Gutiérrez-Velázquez, Marcela Verónica and Torres-Ricario, Rene},
title = {Phytochemical Profiling, Toxicological Safety, and Antihyperglycemic Effects of Fouquieria splendens Engelm. Foliar Extract in Streptozotocin-Induced Diabetic Rats},
journal = {Future Pharmacology},
year = {2025},
volume = {5},
number = {4},
pages = {64},
doi = {10.3390/futurepharmacol5040064}
}
EUVIMED